학술논문

Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.
Document Type
Article
Source
Oncologist; Feb2024, Vol. 29 Issue 2, pe266-e274, 9p
Subject
BIOMARKERS
CLINICAL trials
MULTIVARIATE analysis
ANTINEOPLASTIC agents
MONOCLONAL antibodies
TREATMENT effectiveness
IMMUNITY
ADVERSE health care events
PREDICTION models
IMMUNOTHERAPY
PROPORTIONAL hazards models
Language
ISSN
10837159
Abstract
Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)